Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

F1000Research
Jun YongMartin Walshaw

Abstract

Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation.

References

Dec 17, 2009·Hematology·George Garratty
Jun 3, 2014·Blood Transfusion = Trasfusione Del Sangue·Fei Chen, Zhuying Zhan

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
electrophoresis

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Related Papers

Blood Transfusion = Trasfusione Del Sangue
Fei Chen, Zhuying Zhan
The Indian Practitioner
V P Mital, P K Wahal
British Journal of Haematology
Quentin A HillBritish Society for Haematology Guidelines
© 2022 Meta ULC. All rights reserved